✦ LIBER ✦

1034 REAL-WORLD MANAGEMENT OF HCC WITH SORAFENIB AND TACE IN EUROPE FROM GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB)

✍ Scribed by Stal, P.; Hubert, A.; Daniele, B.; Bronowicki, J.-P.; Mathurin, P.; Gerolami, R.; Bodoky, G.; Vázquez, J.T.; Serejo, F.; Croitoru, A.; Castells, L.; Gorbunova, V.; Ratziu, V.; Papandreou, C.

Book ID: 122717494
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 69 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61046-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1021 GLOBAL INVESTIGATION OF THERAPEUTIC

1021 GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA (HCC) AND OF ITS TREATMENT WITH SORAFENIB (GIDEON): IMPACT OF LIVER DYSFUNCTION ON SORAFENIB TREATMENT IN EUROPE

✍ Mathurin, P.; Castells, L.; Bodoky, G.; Stäal, P.; Bronowicki, J.-P.; Gerolami, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 112 KB

81 GIDEON (GLOBAL INVESTIGATION OF THERA

81 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB) STUDY FIRST INTERIM RESULTS: SORAFENIB DOSING ACROSS REGIONS AND DISEASE SUBGROUPS

✍ J.-P. Bronowicki; R. Lencioni; A. Venook; J. Marrero; M. Kudo; S.-L. Ye; K. Naka 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Abstract No. 241: Worldwide trends in lo

Abstract No. 241: Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): First interim analysis of the global investigation of therapeutic decisions in HCC and of its treatment with sorafenib (GIDEON) study

✍ Geschwind, J.F.; Lencioni, R.; Marrero, J.; Venook, A.; Ye, S.; Nakajima, K.; Ku 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

GIDEON (Global Investigation of therapeu

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

✍ Lencioni, R.; Kudo, M.; Ye, S.-L.; Bronowicki, J.-P.; Chen, X.-P.; Dagher, L.; F 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

6500 ORAL Second Interim Results of the

6500 ORAL Second Interim Results of the GIDEON (Global Investigation of Therapeutic DEcisions in HCC and of Its Treatment With SorafeNib) Study – Barcelona-Clinic Liver Cancer (BCLC) Stage Subgroup Analysis

✍ Lencioni, R.; Venook, A.P.; Marrero, J.A.; Kudo, M.; Ye, S.L.; Nakajima, K.; Cih 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Abstract No. 196: Worldwide trends in lo

Abstract No. 196: Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study

✍ Geschwind, J.F.; Lencioni, R.; Marrero, J.; Venook, A.; Ye, S.; Nakajima, K.; Ku 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB